Novo Nordisk's Remarkable Growth

Novo Nordisk's market cap has skyrocketed to over $400 billion, despite a challenging market backdrop. Their revenue has also seen significant growth, reaching $30 billion in 2022. With a focus on GLP one drugs, the company has become incredibly profitable, making $10 billion in net income annually.